Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.


Search All Patents:



  This Patent May Be For Sale or Lease. Contact Us

  Is This Your Patent? Claim This Patent Now.



Register or Login To Download This Patent As A PDF




United States Patent 9,161,757
Bettuchi October 20, 2015

Hub for positioning annular structure on a surgical device

Abstract

An apparatus for forming an anastomosis between adjacent intestinal sections is provided. The apparatus includes an anastomosis device having a cartridge assembly; and an anvil assembly having a shaft extending therefrom and a connection feature on the shaft. The apparatus further including a hub having a connection portion selectively attachable to the connection feature of the shaft, the connection portion defining a lumen for receiving the shaft; and an annular structure operatively connected to the hub and extending radially outwardly therefrom, the hub being arranged for locating the annular structure between the adjacent intestinal sections when connected to the shaft.


Inventors: Bettuchi; Michael J. (Middletown, CT)
Applicant:
Name City State Country Type

Bettuchi; Michael J.

Middletown

CT

US
Assignee: Covidien LP (Mansfield, MA)
Family ID: 1000001409379
Appl. No.: 12/825,709
Filed: June 29, 2010


Prior Publication Data

Document IdentifierPublication Date
US 20100264195 A1Oct 21, 2010

Related U.S. Patent Documents

Application NumberFiling DatePatent NumberIssue Date
11365636Feb 28, 20067793813

Current U.S. Class: 1/1
Current CPC Class: A61B 17/115 (20130101); A61B 17/07292 (20130101); A61B 17/1155 (20130101)
Current International Class: A61B 17/10 (20060101); A61B 17/115 (20060101); A61B 17/072 (20060101)
Field of Search: ;606/153,219 ;227/175.1,176.1,179.1

References Cited [Referenced By]

U.S. Patent Documents
3054406 September 1962 Usher
3124136 March 1964 Usher
4347847 September 1982 Usher
4354628 October 1982 Green
4452245 June 1984 Usher
4605730 August 1986 Shalaby et al.
4655221 April 1987 Devereux
4834090 May 1989 Moore
4838884 June 1989 Dumican et al.
4927640 May 1990 Dahlinder et al.
4930674 June 1990 Barak
5002551 March 1991 Linsky et al.
5014899 May 1991 Presty et al.
5040715 August 1991 Green et al.
5065929 November 1991 Schulze et al.
5205459 April 1993 Brinkerhoff et al.
5263629 November 1993 Trumbull et al.
5314471 May 1994 Brauker et al.
5344454 September 1994 Clarke et al.
5392979 February 1995 Green et al.
5397324 March 1995 Carroll et al.
5425745 June 1995 Green et al.
5441193 August 1995 Gravener
5441507 August 1995 Wilk et al.
5443198 August 1995 Viola et al.
5468253 November 1995 Bezwada et al.
5503638 April 1996 Cooper et al.
5542594 August 1996 McKean et al.
5549628 August 1996 Cooper et al.
5575803 November 1996 Cooper et al.
5653756 August 1997 Clarke et al.
5669918 September 1997 Balazs et al.
5683809 November 1997 Freeman et al.
5690675 November 1997 Sawyer et al.
5702409 December 1997 Rayburn et al.
5752965 May 1998 Francis et al.
5762256 June 1998 Mastri et al.
5766188 June 1998 Igaki
5769892 June 1998 Kingwell
5782396 July 1998 Mastri et al.
5799857 September 1998 Robertson et al.
5810855 September 1998 Rayburn et al.
5814057 September 1998 Oi et al.
5833695 November 1998 Yoon
5843096 December 1998 Igaki et al.
5895412 April 1999 Tucke
5902312 May 1999 Frater et al.
5908427 June 1999 McKean et al.
5915616 June 1999 Viola et al.
5931847 August 1999 Bittner et al.
5964774 October 1999 McKean et al.
5997895 December 1999 Narotam et al.
6019791 February 2000 Wood
6030392 February 2000 Dakov et al.
6032849 March 2000 Mastri et al.
6045560 April 2000 McKean et al.
6063097 May 2000 Oi et al.
6080169 June 2000 Turtel
6099551 August 2000 Gabbay
6149667 November 2000 Hovland et al.
6155265 December 2000 Hammerslag
6210439 April 2001 Firmin et al.
6214020 April 2001 Mulhauser et al.
6241139 June 2001 Milliman et al.
6258107 July 2001 Balazs et al.
6267772 July 2001 Mulhauser et al.
6273897 August 2001 Dalessandro et al.
6280453 August 2001 Kugel et al.
6299631 October 2001 Shalaby
6312457 November 2001 DiMatteo et al.
6312474 November 2001 Francis et al.
6325810 December 2001 Hamilton et al.
6436030 August 2002 Rehil
6454780 September 2002 Wallace
6461368 October 2002 Fogarty et al.
6503257 January 2003 Grant et al.
6514283 February 2003 DiMatteo et al.
6517566 February 2003 Hovland et al.
6551356 April 2003 Rousseau
6592597 July 2003 Grant et al.
6638285 October 2003 Gabbay
6652594 November 2003 Francis et al.
6656193 December 2003 Grant
6669735 December 2003 Pelissier
6676671 January 2004 Robertson et al.
6677258 January 2004 Carroll et al.
6685714 February 2004 Rousseau
6704210 March 2004 Myers
6723114 April 2004 Shalaby
6726706 April 2004 Dominguez
6736823 May 2004 Darois et al.
6736854 May 2004 Vadurro et al.
6746458 June 2004 Cloud
6773458 August 2004 Brauker et al.
6927315 August 2005 Heinecke et al.
6959851 November 2005 Heinrich
7128748 October 2006 Mooradian et al.
7147138 December 2006 Shelton, IV
7434717 October 2008 Shelton, IV et al.
7438209 October 2008 Hess et al.
7547312 June 2009 Bauman et al.
7559937 July 2009 de la Torre et al.
7604151 October 2009 Hess et al.
7665646 February 2010 Prommersberger
7669747 March 2010 Weisenburgh, II et al.
7717313 May 2010 Bettuchi et al.
7722642 May 2010 Williamson, IV
7744627 June 2010 Orban, III et al.
7776060 August 2010 Mooradian
7793813 September 2010 Bettuchi
7799026 September 2010 Schechter et al.
7823592 November 2010 Bettuchi et al.
7845533 December 2010 Marczyk et al.
7845536 December 2010 Viola et al.
7846149 December 2010 Jankowski
7909224 March 2011 Prommersberger
7950561 May 2011 Aranyi
7951166 May 2011 Orban
7967179 June 2011 Olson
7988027 August 2011 Olson
8011550 September 2011 Aranyi
8016177 September 2011 Bettuchi
8016178 September 2011 Olson
8028883 October 2011 Stopek
8062330 November 2011 Prommersberger
8083119 December 2011 Prommersberger
8123766 February 2012 Bauman
8123767 February 2012 Bauman
8146791 April 2012 Bettuchi
8157149 April 2012 Olson
8157151 April 2012 Ingmanson
8167895 May 2012 D'Agostino
8192460 June 2012 Orban
8210414 July 2012 Bettuchi
8225799 July 2012 Bettuchi
8225981 July 2012 Criscuolo et al.
8231043 July 2012 Tarinelli
8235273 August 2012 Olson
8245901 August 2012 Stopek
8256654 September 2012 Bettuchi
8257391 September 2012 Orban
8276800 October 2012 Bettuchi
8286849 October 2012 Bettuchi
8308042 November 2012 Aranyi
8308045 November 2012 Bettuchi
8308046 November 2012 Prommersberger
8312885 November 2012 Bettuchi
8313014 November 2012 Bettuchi
8348126 January 2013 Olson
8348130 January 2013 Shah
8365972 February 2013 Aranyi et al.
8371491 February 2013 Huitema
8371492 February 2013 Aranyi
8371493 February 2013 Aranyi
8393514 March 2013 Shelton, IV
8408440 April 2013 Olson
8413871 April 2013 Racenet
8424742 April 2013 Bettuchi
8453652 June 2013 Stopek
8453904 June 2013 Eskaros
8453909 June 2013 Olson
8453910 June 2013 Bettuchi
8464925 June 2013 Hull et al.
8474677 July 2013 Woodard, Jr.
8479968 July 2013 Hodgkinson
8485414 July 2013 Criscuolo et al.
8496683 July 2013 Prommersberger
8511533 August 2013 Viola
8512402 August 2013 Marczyk
8529600 September 2013 Woodard, Jr.
8540131 September 2013 Swayze
8551138 October 2013 Orban
8556918 October 2013 Bauman
8561873 October 2013 Ingmanson
8584920 November 2013 Hodgkinson
8590762 November 2013 Hess
8616430 December 2013 Prommersberger
8631989 January 2014 Aranyi
8668129 March 2014 Olson
8684250 April 2014 Bettuchi
8757466 June 2014 Olson
8789737 July 2014 Hodgkinson
8820606 September 2014 Hodgkinson
8870050 October 2014 Hodgkinson
8939344 January 2015 Olson et al.
8967448 March 2015 Carter et al.
9005243 April 2015 Stopek et al.
9010606 April 2015 Aranyi et al.
9010608 April 2015 Casasanta, Jr. et al.
9010609 April 2015 Carter et al.
9010610 April 2015 Hodgkinson
9010612 April 2015 Stevenson et al.
9016543 April 2015 Stopek et al.
9016544 April 2015 Hodgkinson et al.
2002/0016626 February 2002 DiMatteo et al.
2002/0019187 February 2002 Carroll et al.
2002/0028243 March 2002 Masters
2002/0052622 May 2002 Rousseau
2002/0091397 July 2002 Chen
2002/0133236 September 2002 Rousseau
2002/0138152 September 2002 Francis et al.
2002/0151911 October 2002 Gabbay
2002/0165559 November 2002 Grant et al.
2002/0165562 November 2002 Grant et al.
2002/0165563 November 2002 Grant et al.
2002/0177859 November 2002 Monassevitch et al.
2003/0065345 April 2003 Weadock
2003/0065346 April 2003 Evens et al.
2003/0083676 May 2003 Wallace
2003/0088256 May 2003 Conston et al.
2003/0105510 June 2003 DiMatteo et al.
2003/0114866 June 2003 Ulmsten et al.
2003/0120284 June 2003 Palacios
2003/0167064 September 2003 Whayne
2003/0181927 September 2003 Wallace
2003/0183671 October 2003 Mooradian et al.
2003/0208231 November 2003 Williamson, IV et al.
2004/0034377 February 2004 Sharkawy et al.
2004/0092960 May 2004 Abrams et al.
2004/0093029 May 2004 Zubik et al.
2004/0107006 June 2004 Francis et al.
2004/0116945 June 2004 Sharkawy et al.
2004/0142621 July 2004 Carroll et al.
2004/0172048 September 2004 Browning
2004/0209059 October 2004 Foss
2004/0215214 October 2004 Crews et al.
2004/0215219 October 2004 Eldridge et al.
2004/0215221 October 2004 Suyker et al.
2004/0254590 December 2004 Hoffman et al.
2004/0260315 December 2004 Dell et al.
2005/0002981 January 2005 Lahtinen et al.
2005/0021026 January 2005 Baily
2005/0021053 January 2005 Heinrich
2005/0021085 January 2005 Abrams et al.
2005/0059996 March 2005 Bauman et al.
2005/0059997 March 2005 Bauman et al.
2005/0070929 March 2005 Dalessandro et al.
2005/0080437 April 2005 Wright
2005/0118435 June 2005 DeLucia et al.
2005/0143756 June 2005 Jankowski
2005/0149073 July 2005 Arani et al.
2005/0228446 October 2005 Mooradian et al.
2005/0245965 November 2005 Orban et al.
2006/0004407 January 2006 Hiles et al.
2006/0085034 April 2006 Bettuchi
2006/0135992 June 2006 Bettuchi et al.
2006/0173470 August 2006 Oray et al.
2006/0178683 August 2006 Shimoji et al.
2006/0212050 September 2006 D'Agostino et al.
2006/0271104 November 2006 Viola et al.
2007/0026031 February 2007 Bauman et al.
2007/0034669 February 2007 de la Torre et al.
2007/0049953 March 2007 Shimoji et al.
2007/0123839 May 2007 Rousseau et al.
2007/0179528 August 2007 Soltz et al.
2007/0203509 August 2007 Bettuchi
2007/0203510 August 2007 Bettuchi
2007/0243227 October 2007 Gertner
2007/0246505 October 2007 Pace-Floridia et al.
2008/0029570 February 2008 Shelton et al.
2008/0082126 April 2008 Murray et al.
2008/0110959 May 2008 Orban et al.
2008/0125812 May 2008 Zubik et al.
2008/0140115 June 2008 Stopek
2008/0161831 July 2008 Bauman et al.
2008/0161832 July 2008 Bauman et al.
2008/0169327 July 2008 Shelton et al.
2008/0169328 July 2008 Shelton
2008/0169329 July 2008 Shelton et al.
2008/0169330 July 2008 Shelton et al.
2008/0169331 July 2008 Shelton et al.
2008/0169332 July 2008 Shelton et al.
2008/0169333 July 2008 Shelton et al.
2008/0200949 August 2008 Hiles
2008/0220047 September 2008 Sawhney et al.
2008/0230583 September 2008 Heinrich
2008/0290134 November 2008 Bettuchi et al.
2008/0308608 December 2008 Prommersberger
2008/0314960 December 2008 Marczyk et al.
2009/0001121 January 2009 Hess et al.
2009/0001122 January 2009 Prommersberger et al.
2009/0001123 January 2009 Morgan et al.
2009/0001124 January 2009 Hess et al.
2009/0001125 January 2009 Hess et al.
2009/0001126 January 2009 Hess et al.
2009/0001128 January 2009 Weisenburgh, II et al.
2009/0001130 January 2009 Hess et al.
2009/0005808 January 2009 Hess et al.
2009/0030452 January 2009 Bauman et al.
2009/0043334 February 2009 Bauman et al.
2009/0076510 March 2009 Bell et al.
2009/0076528 March 2009 Sgro
2009/0078739 March 2009 Viola
2009/0095791 April 2009 Eskaros et al.
2009/0095792 April 2009 Bettuchi
2009/0120994 May 2009 Murray et al.
2009/0134200 May 2009 Tarinelli et al.
2009/0206125 August 2009 Huitema et al.
2009/0206126 August 2009 Huitema et al.
2009/0206139 August 2009 Hall et al.
2009/0206141 August 2009 Huitema et al.
2009/0206142 August 2009 Huitema et al.
2009/0206143 August 2009 Huitema et al.
2009/0218384 September 2009 Aranyi
2009/0277947 November 2009 Viola
2009/0287230 November 2009 D'Agostino et al.
2010/0012704 January 2010 Tarinelli Racenet et al.
2010/0065606 March 2010 Stopek
2010/0065607 March 2010 Orban, III et al.
2010/0072254 March 2010 Aranyi et al.
2010/0147921 June 2010 Olson
2010/0147922 June 2010 Olson
2010/0147923 June 2010 D'Agostino et al.
2010/0243707 September 2010 Olson et al.
2010/0243708 September 2010 Aranyi et al.
2010/0243711 September 2010 Olson et al.
2010/0249805 September 2010 Olson et al.
2010/0264195 October 2010 Bettuchi
2010/0282815 November 2010 Bettuchi et al.
2011/0024476 February 2011 Bettuchi et al.
2011/0024481 February 2011 Bettuchi et al.
2011/0036894 February 2011 Bettuchi
2011/0042442 February 2011 Viola et al.
2011/0046650 February 2011 Bettuchi
2011/0057016 March 2011 Bettuchi
2011/0087279 April 2011 Shah et al.
2011/0215132 September 2011 Aranyi
2012/0074199 March 2012 Olson
2012/0080336 April 2012 Shelton
2012/0187179 July 2012 Gleiman
2012/0241499 September 2012 Baxter
2012/0273547 November 2012 Hodgkinson et al.
2013/0037596 February 2013 Bear et al.
2013/0105548 May 2013 Hodgkinson
2013/0105553 May 2013 Racenet
2013/0112732 May 2013 Aranyi
2013/0112733 May 2013 Aranyi
2013/0146641 June 2013 Shelton
2013/0153633 June 2013 Casasanta
2013/0153634 June 2013 Carter
2013/0153635 June 2013 Hodgkinson
2013/0153636 June 2013 Shelton
2013/0153638 June 2013 Carter
2013/0153639 June 2013 Hodgkinson
2013/0153640 June 2013 Hodgkinson
2013/0153641 June 2013 Shelton
2013/0161374 June 2013 Swayze
2013/0181031 July 2013 Olson
2013/0193186 August 2013 Racenet
2013/0193190 August 2013 Carter
2013/0193191 August 2013 Stevenson
2013/0193192 August 2013 Casasanta
2013/0209659 August 2013 Racenet
2013/0221062 August 2013 Hodgkinson
2013/0240600 September 2013 Bettuchi
2013/0240601 September 2013 Bettuchi
2013/0240602 September 2013 Stopek
2013/0277411 October 2013 Hodgkinson
2013/0306707 November 2013 Viola
2013/0310873 November 2013 Prommersberger
2013/0327807 December 2013 Olson
2014/0012317 January 2014 Orban
2014/0021242 January 2014 Hodgkinson
2014/0027490 January 2014 Marczyk
2014/0034704 February 2014 Ingmanson
2014/0048580 February 2014 Merchant
2014/0061280 March 2014 Ingmanson
2014/0061281 March 2014 Hodgkinson
2014/0084042 March 2014 Stopek
2014/0097224 April 2014 Prior
2014/0117066 May 2014 Aranyi
2014/0130330 May 2014 Olson
2014/0131418 May 2014 Kostrzewski
2014/0131419 May 2014 Bettuchi
2014/0138423 May 2014 Whitfield
2014/0151431 June 2014 Hodgkinson
2014/0155916 June 2014 Hodgkinson
2014/0158742 June 2014 Stopek
2014/0166721 June 2014 Stevenson
2014/0197224 July 2014 Penna
2014/0203061 July 2014 Hodgkinson
2014/0217147 August 2014 Milliman
2014/0217148 August 2014 Penna
2014/0239046 August 2014 Milliman
2014/0239047 August 2014 Hodgkinson
2014/0252062 September 2014 Mozdzierz
2015/0001276 January 2015 Hodgkinson et al.
2015/0041347 February 2015 Hodgkinson
2015/0097018 April 2015 Hodgkinson
2015/0115015 April 2015 Prescott et al.
Foreign Patent Documents
2 667 434 May 2008 CA
1 99 24 311 Nov 2000 DE
199 24 311 Nov 2000 DE
0 594 148 Apr 1994 EP
0 327 022 Apr 1995 EP
0 667 119 Aug 1995 EP
1 064 883 Jan 2001 EP
1 256 317 Nov 2002 EP
1 256 318 Nov 2002 EP
1 520 525 Apr 2005 EP
1 621 141 Feb 2006 EP
1 702 570 Sep 2006 EP
1 759 640 Mar 2007 EP
1 815 804 Aug 2007 EP
1 825 820 Aug 2007 EP
1 929 958 Jun 2008 EP
1 994 890 Nov 2008 EP
2 005 894 Dec 2008 EP
2 005 895 Dec 2008 EP
2 008 595 Dec 2008 EP
2 090 231 Aug 2009 EP
2 090 244 Aug 2009 EP
2 090 252 Aug 2009 EP
2 198 787 Jun 2010 EP
2 236 098 Oct 2010 EP
2 236 099 Oct 2010 EP
2 292 276 Mar 2011 EP
2 311 386 Apr 2011 EP
2 436 348 Apr 2012 EP
2 462 880 Jun 2012 EP
2 517 637 Oct 2012 EP
2 586 380 May 2013 EP
2 604 195 Jun 2013 EP
2 604 197 Jun 2013 EP
2 620 105 Jul 2013 EP
2 620 106 Jul 2013 EP
2 630 922 Aug 2013 EP
2 644 125 Oct 2013 EP
2 762 091 Aug 2014 EP
2000-166933 Jun 2000 JP
2002-202213 Jul 2002 JP
07-124166 May 2007 JP
WO 90/05489 May 1990 WO
WO 95/016221 Jun 1995 WO
WO 96/22055 Jul 1996 WO
WO 97/01989 Jan 1997 WO
WO 97/13463 Apr 1997 WO
WO 98/17180 Apr 1998 WO
WO 99/45849 Sep 1999 WO
WO 03/082126 Oct 2003 WO
WO 03/088845 Oct 2003 WO
WO 03/094743 Nov 2003 WO
WO 03/105698 Dec 2003 WO
WO 03/105698 Dec 2003 WO
WO 2005/079675 Sep 2005 WO
WO 2006/023578 Mar 2006 WO
WO 2006/044490 Apr 2006 WO
WO 2006/083748 Aug 2006 WO
WO 2007/121579 Nov 2007 WO
WO 2008/057281 May 2008 WO
WO 2008/109125 Sep 2008 WO
WO 2010/075298 Jul 2010 WO
WO 2011/143183 Nov 2011 WO
WO 2012/044848 Apr 2012 WO

Other References

Extended European Search Report corresponding to EP No. 12 19 1035.0, completed Jan. 11, 2013 and mailed Jan. 18, 2013; 7 pages. cited by applicant .
Extended European Search Report corresponding to EP No. 12 18 6175.1, completed Jan. 15, 2013 and mailed Jan. 23, 2013; 7 pages. cited by applicant .
Extended European Search Report corresponding to EP No. 12 19 1114.3, completed Jan. 23, 2013 and mailed Jan. 31, 2013; 10 pages. cited by applicant .
Extended European Search Report corresponding to EP No. 12 19 2224.9, completed Mar. 14, 2013 and mailed Mar. 26, 2013; 8 pages. cited by applicant .
Extended European Search Report corresponding to EP No. 12 19 6911.7, completed Apr. 18, 2013 and mailed Apr. 24, 2013; 8 pages. cited by applicant .
International Search Report corresponding to European Application No. EP 06016962.0, dated Jan. 3, 2007; (6 pages). cited by applicant .
International Search Report corresponding to International Application No. PCT/US05/36740, dated Mar. 23, 2007; (1 page). cited by applicant .
International Search Report corresponding to International Application No. PCT/US2008/002981, dated Jun. 26, 2008; (1 page). cited by applicant .
International Search Report corresponding to European Application No. EP 08 25 1779, dated Jul. 14, 2008 (2 pages). cited by applicant .
International Search Report corresponding to European Application No. EP 11 18 8309.6, completed on Dec. 15, 2011 and mailed on Jan. 12, 2012; 3 pages. cited by applicant .
International Search Report corresponding to European Application No. EP 10 25 0715.9, completed on Jun. 30, 2010 and mailed on Jul. 20, 2010; 3 pages. cited by applicant .
International Search Report corresponding to European Application No. EP 10 25 0642.5, completed on Mar. 25, 2011 and mailed on Apr. 4, 2011; 4 pages. cited by applicant .
International Search Report corresponding to European Application No. EP 12 15 2229.6, completed on Feb. 23, 2012 and mailed on Mar. 1, 2012; 4 pages. cited by applicant .
International Search Report corresponding to European Application No. EP 12 15 0511.9, completed on Apr. 16, 2012 and mailed on Apr. 24, 2012; 7 pages. cited by applicant .
International Search Report corresponding to European Application No. EP 12 15 2541.4, completed on Apr. 23, 2012 and mailed on May 3, 2012; 10 pages. cited by applicant .
International Search Report corresponding to European Application No. EP 12 16 5609.4, completed on Jul. 5, 2012 and mailed on Jul. 13, 2012; 8 pages. cited by applicant .
International Search Report corresponding to European Application No. EP 12 15 8861.0, completed on Jul. 17, 2012 and mailed on Jul. 24, 2012; 9 pages. cited by applicant .
International Search Report corresponding to European Application No. EP 12 16 5878.5, completed on Jul. 24, 2012 and mailed on Aug. 6, 2012; 8 pages. cited by applicant .
International Search Report corresponding to European Application No. EP 06 00 4598, completed on Jun. 22, 2006; 2 pages. cited by applicant .
International Search Report corresponding to European Application No. EP 06 01 6962.0, completed on Jan. 3, 2007 and mailed on Jan. 11, 2007; 10 pages. cited by applicant .
International Search Report corresponding to International Application No. PCT/US05/36740, completed on Feb. 20, 2007 and mailed on Mar. 23, 2007; 8 pages. cited by applicant .
International Search Report corresponding to International Application No. PCT/US2008/002981, completed on Jun. 9, 2008 and mailed on Jun. 26, 2008; 2 pages. cited by applicant .
International Search Report corresponding to European Application No. EP 08 25 1779, completed on Jul. 14, 2008 and mailed on Jul. 23, 2008; 5 pages. cited by applicant .
International Search Report corresponding to European Application No. EP 08 25 1989.3, completed on Mar. 11, 2010 and mailed on Mar. 24, 2010; 3 pages. cited by applicant .
International Search Report corresponding to European Application No. EP 05 80 4382.9, completed on Oct. 5, 2010 and mailed on Oct. 12, 2010; 3 pages. cited by applicant .
International Search Report corresponding to European Application No. EP 10 25 1437.9, completed on Nov. 22, 2010 and mailed on Dec. 16, 2010; 3 pages. cited by applicant .
International Search Report corresponding to European Application No. EP 09 25 2897.5, completed on Feb. 7, 2011 and mailed on Feb. 15, 2011; 3 pages. cited by applicant .
Extended European Search Report corresponding to EP 12 19 1035.0, completed Jan. 11, 2013 and mailed Jan. 18, 2013; 7 pages. cited by applicant .
Extended European Search Report corresponding to EP 12 19 6904.2, completed Mar. 28, 2013 and mailed Jul. 26, 2013; 8 pages. cited by applicant .
Extended European Search Report corresponding to EP 12 19 8749.9, completed May 21, 2013 and mailed May 31, 2013; 8 pages. cited by applicant .
Extended European Search Report corresponding to EP 07 00 5842.5, completed May 13, 2013 and mailed May 29, 2013; 7 pages. cited by applicant .
Extended European Search Report corresponding to EP 12 19 8776.2, completed May 16, 2013 and mailed May 27, 2013; 8 pages. cited by applicant .
Extended European Search Report corresponding to EP 13 15 6297.7, completed Jun. 4, 2013 and mailed Jun. 13, 2013; 7 pages. cited by applicant .
Extended European Search Report corresponding to EP 13 17 3985.6, completed Aug. 19, 2013 and mailed Aug. 28, 2013; 6 pages. cited by applicant .
Extended European Search Report corresponding to EP 13 17 3986.4, completed Aug. 20, 2013 and mailed Aug. 29, 2013; 7 pages. cited by applicant .
Extended European Search Report corresponding to EP 13 17 7437.4, completed Sep. 11, 2013 and mailed Sep. 19, 2013; (6 pp). cited by applicant .
Extended European Search Report correspending to EP 13 17 7441.6, completed Sep. 11, 2013 and mailed Sep. 19, 2013; (6 pp). cited by applicant .
Extended European Search Report correspending to EP 07 86 1534.1, completed Sep. 20, 2013 and mailed Sep. 30, 2013; (5 pp). cited by applicant .
Extended European Search Report correspending to EP 13 18 3876.5, completed Oct. 14, 2013 and mailed Oct. 24, 2013; (5 pp). cited by applicant .
Extended European Search Report correspending to EP 13 17 1856.1, completed Oct. 29, 2013 and mailed Nov. 13, 2013; (8 pp). cited by applicant .
Extended European Search Report correspending to EP 13 18 0373.6, completed Oct. 31, 2013 and mailed Nov. 13, 2013; (7 pp). cited by applicant .
Extended European Search Report correspending to EP 13 18 0881.8, completed Nov. 5, 2013 and mailed Nov. 14, 2013; (6 pp). cited by applicant .
Extended European Search Report correspending to EP 13 17 6895.4, completed Nov. 29, 2013 and mailed Dec. 12, 2013; (5 pp). cited by applicant .
Extended European Search Report correspending to EP 13 18 2911.1, completed Dec. 2, 2013 and mailed Dec. 16, 2013; (8 pp). cited by applicant .
Extended European Search Report correspending to EP 10 25 1795.0, completed Dec. 11, 2013 and mailed Dec. 20, 2013; (6 pp). cited by applicant .
Extended European Search Report correspending to EP 13 18 7911.6, completed Jan. 22, 2014 and mailed Jan. 31, 2014; (8 pp). cited by applicant .
Extended European Search Report corresponding to EP 08 72 6500.5, completed Feb. 20, 2014 and mailed Mar. 3, 2014; (7 pp). cited by applicant .
Extended European Search Report corresponding to EP 13 19 5919.9, completed Feb. 10, 2014 and mailed Mar. 3, 2014; (7 pp). cited by applicant .
Extended European Search Report corresponding to EP 13 19 2123.1, completed Jan. 30, 2014 and mailed Feb. 10, 2014; (8 pp). cited by applicant .
Extended European Search Report corresponding to EP 13 19 6816.6, completed Mar. 28, 2014 and mailed Apr. 9, 2014; (9 pp). cited by applicant .
Extended European Search Report corresponding to EP 13 19 4995.0, completed Jun. 5, 2014 and mailed Jun. 16, 2014; (5 pp). cited by applicant .
Extended European Search Report corresponding to EP 13 19 5019.8, completed Mar. 14, 2014 and mailed Mar. 24, 2014; (7 pp). cited by applicant .
Extended European Search Report corresponding to EP 13 19 2111.6, completed Feb. 13, 2014 and mailed Feb. 27, 2014; (10 pp). cited by applicant .
Extended European Search Report corresponding to EP 13 19 7958.5, completed Apr. 4, 2014 and mailed Apr. 15, 2014; (8 pp). cited by applicant .
Extended European Search Report corresponding to EP 14 15 6342.9, completed Jul. 22, 2014 and mailed Jul. 29, 2014; (8 pp). cited by applicant .
Extended European Search Report corresponding to EP 14 15 7195.0, completed Jun. 5, 2014 and mailed Jun. 18, 2014; (9 pp). cited by applicant .
Extended European Search Report corresponding to EP 14 16 9739.1, completed Aug. 19, 2014 and Aug. 29, 2014; (7 pp). cited by applicant .
Extended European Search Report corresponding to EP 14 15 7997.9, completed Sep. 9, 2014 and mailed Sep. 17, 2014; (8 pp). cited by applicant .
Extended European Search Report corresponding to EP 14 16 8904.2, completed Sep. 10, 2014 and mailed Sep. 18, 2014; (8 pp). cited by applicant .
Extended European Search Report corresponding to EP 13 19 4995.0, completed Jun. 5, 2014 and mailed Oct. 13, 2014; (10 pp). cited by applicant .
Extended European Search Report corresponding to EP 13 15 4571.7, completed Oct. 10, 2014 and mailed Oct. 20, 2014; (8 pp). cited by applicant .
Extended European Search Report corresponding to EP 14 18 1125.7, completed Oct. 16, 2014 and mailed Oct. 24, 2014; (7 pp). cited by applicant .
Extended European Search Report corresponding to EP 14 18 1127.3, completed Oct. 16, 2014 and mailed Nov. 10, 2014; (8 pp). cited by applicant .
Extended European Search Report corresponding to EP 14 19 0419.3, completed Mar. 24, 2015 and mailed Mar. 30, 2015; (6 pp). cited by applicant.

Primary Examiner: Shi; Katherine M
Assistant Examiner: Bachman; Lindsey

Parent Case Text



CROSS-REFERENCE TO RELATED APPLICATIONS

The present application is a Divisional Application of prior U.S. patent application Ser. No. 11/365,636, filed Feb. 28, 2006, now U.S. Pat. No. 7,793,813, the entire content of which is incorporated herein by reference.
Claims



What is claimed is:

1. A method of disposing an annular structure between adjacent tissue sections, the method comprising the steps of: a) providing a surgical stapling device including an anvil assembly and a body portion, the anvil assembly including an anvil member supported on an anvil shaft and the body portion carrying a plurality of surgical staples and a knife; b) providing a hub for locating an annular structure between the adjacent tissue sections, the hub including a central sleeve having a first end and a second end defining a lumen therebetween, the central sleeve configured to selectively receive and engage the anvil shaft of the anvil assembly, and an annular structure extending from the first end of the central sleeve and extending radially outwardly therefrom; c) inserting the anvil assembly into a first tissue section such that the anvil member is positioned adjacent to a first side of the first tissue section; d) after the anvil assembly is inserted into the first tissue section, positioning the hub onto the anvil shaft by inserting the anvil shaft through the first end of the hub and towards the second end of the hub such that the annular structure is concentrically located with respect to a longitudinal axis of the anvil shaft and such that the annular structure is positioned immediately adjacent to a second side of the first tissue section that is opposed to the first side of the first tissue section; e) inserting the body portion into a second tissue section; f) approximating the anvil assembly, hub and body portion with one another so that an end portion of the first tissue section, an end portion of the second tissue section and the annular structure are disposed between the anvil member and the body portion; and g) connecting the anvil assembly to the surgical stapling device so that a proximal end of the anvil shaft is connected to a connection member mounted within the body portion of the surgical stapling device, wherein the annular structure is disposed between the first tissue section and the second tissue section.

2. The method according to claim 1, further comprising the steps of: a) deploying the staples from the body portion; and b) cutting the first tissue section, the second tissue section, and the annular structure with the knife.

3. The method according to claim 1, wherein the annular structure is an annular flange monolithically formed with the central sleeve.

4. The method according to claim 1, wherein the central sleeve includes a plurality of longitudinally extending slots formed around a periphery thereof.

5. The method according to claim 4, wherein each slot extends through one end of the central sleeve.

6. The method according to claim 1, wherein the annular structure is fabricated from at least one of a bioabsorbable or a non-absorbable material.

7. The method according to claim 6, wherein the annular structure comprises a material, the material selected from the group consisting of an adhesive, a sealant, a hemostat, and a medicament.

8. The method according to claim 1, wherein the annular structure includes an outer annular disc defining a central opening having a dimension larger than an outer diameter of the central sleeve, and a web interconnecting the disc to the central sleeve.

9. The method of claim 1, wherein positioning the hub onto the anvil shaft includes positioning the central sleeve of the hub distal to the annular structure of the hub on the anvil shaft.

10. The method of claim 8, wherein the web is a mesh.
Description



BACKGROUND

1. Technical Field

The present disclosure relates to annular structures and devices for positioning the same and, more particularly, to hubs for positioning annular structures, gaskets and the like for use in conjunction with circular stapling devices, for reducing occurrences of leaking, bleeding and/or stricture.

2. Background of Related Art

Staples have traditionally been used to replace suturing when joining or anastomosing various body structures, such as, for example, the bowel or bronchus. The surgical stapling devices employed to apply these staples are generally designed to simultaneously cut and seal an extended segment of tissue in a patient, thus vastly reducing the time and risks of such procedures.

Linear or annular surgical stapling devices are employed by surgeons to sequentially or simultaneously apply one or more linear rows of surgical fasteners, e.g., staples or two-part fasteners, to body tissue for the purpose of joining segments of body tissue together and/or for the creation of anastomoses. Linear surgical stapling devices generally include a pair of jaws or finger-like structures between which body tissue to be joined is placed. When the surgical stapling device is actuated and/or "fired", firing bars move longitudinally and contact staple drive members in one of the jaws, and surgical staples are pushed through the body tissue and into/against an anvil in the opposite jaw thereby crimping the staples closed. A knife blade may be provided to cut between the rows/lines of staples. Examples of such surgical stapling devices are described in U.S. Pat. Nos. 4,354,628, 5,014,899 and 5,040,715, the entirety of each of which is incorporated herein by reference.

Annular surgical stapling devices generally include an annular staple cartridge assembly including a plurality of annular rows of staples, typically two, an anvil assembly operatively associated with the annular cartridge assembly, and an annular blade disposed internal of the rows of staples. Examples of such annular surgical stapling devices are described in U.S. Pat. Nos. 5,799,857 and 5,915,616 to Robertson et al., the entirety of each of which is incorporated herein by reference.

For most procedures, the use of bare staples, with the staples in direct contact with the patient's tissue, is generally acceptable. The integrity of the tissue will normally serve to prevent the staples from tearing out of the tissue and compromising the sealing before healing has occurred. However, in some surgical operations, surgical supports, e.g., meshes, are employed by surgeons to bridge, repair and/or reinforce tissue defects with a patient, especially those occurring in the abdominal wall, chest wall, diaphragm and other musculo-aponeurotic areas of the body. Examples of surgical supports are disclosed in U.S. Pat. Nos. 3,054,406, 3,124,136, 4,347,847, 4,655,221, 4,838,884 and 5,002,551, the entirety of each of which is incorporated herein by reference.

When the staples are applied in surgical procedures utilizing surgical supports (i.e., reinforcing material), the legs of the staple typically pass from the cartridge jaw through a layer of the surgical support, and through the patient's tissue before encountering the anvil jaw. In an alternative procedure, the legs of the staple typically pass from the cartridge jaw through a first layer of the surgical support, then through the patient's tissue, and finally through a second layer of the surgical support before encountering the anvil jaw. With the staples in place, the stapled tissue is clamped between the layers of the surgical support.

The surgical supports described above are used in conjunction with linear surgical stapling devices. An end-to-end anastomosis stapler such as a Model "EEA.TM." instrument is available from United States Surgical, a Division of Tyco Health-Care Group, LP, Norwalk, Conn. and disclosed in U.S. Pat. No. 5,392,979 to Green et al. In general, an end-to-end anastomosis stapler typically places an array of staples into the approximated sections of a patient's bowel or other tubular organs. The resulting anastomosis contains an inverted section of bowel which contains numerous "B" shaped staples to maintain a secure connection between the approximated sections of bowel.

In addition to the use of surgical staples, biological tissue adhesives have been developed for tissue repair and the creation of anastomoses. Generally, biological adhesives bond separated tissues together to aid in the healing process and to enhance the tissue strength. Such adhesives may be used instead of suturing and stapling, for example, in surgical procedures, for the repair of tissue or the creation of anastomoses.

In addition to the use of biological adhesives, following the formation of the anastomosis, a separate instrument or device is used to apply biological sealants to the anastomosis. Typically, in a separate step, the biological sealants are applied to the outer surface of the anastomosis by spraying on, brushing on, swabbing on, any combinations thereof, or any other method contemplated by those skilled in the art. The biological sealants act to reduce and/or stop the incidents of leakage from the anastomosis.

One possible side effect of any end-to-end bowel anastomosis is its tendency to stenos over time, which stenosis can decrease the diameter of the lumen over time. Accordingly, the need exists for a structure which assists in maintaining the lumen of the anastomosed bowel or other tubular organ open over time.

The application of a suitable biocompatible adhesive offers many advantages to the patient and the surgeon alike, such as, for example, the possible reduction in the number of staples used, immediate sealing of the tissue being treated, a strengthening of the anastomosis, and a reduction in the occurrence of bleeding from the blood vessels, leakage through the tissue joint, and stricture. Moreover, use of biocompatible adhesives tends to minimize foreign body reaction and scarring.

Accordingly, the need exists for devices for properly positioning a structure with respect to opposed tissue which has been transected.

SUMMARY

The present disclosure relates to hubs for positioning annular support structures, gaskets and the like on delivery devices, for reducing occurrences of leaking, bleeding, stricture and other complications.

According to an aspect of the present disclosure, an apparatus for forming an anastomosis between adjacent intestinal sections is provided. The apparatus includes an anastomosis device including an anvil assembly having a shaft which is selectively attachable to a tubular body portion; and a hub for locating an annular structure between the adjacent intestinal sections. The hub includes a central sleeve defining a lumen for receiving the shaft of the anvil assembly therein. The central sleeve forms a connection portion for engaging a feature on the anastomosis device and connecting the hub to the device. The apparatus further includes an annular structure operatively connected to the sleeve and extending radially outwardly therefrom.

According to another aspect of the present disclosure, an assembly for disposing an annular structure between adjacent intestinal sections is provided. The assembly includes an annular surgical stapling device, having an anvil assembly and a tubular body portion, the anvil assembly having an anvil member and an anvil shaft, the tubular body portion carrying a plurality of surgical staples in an annular configuration, the tubular body portion having a connection member disposed radially inward of the surgical staples, the anvil shaft of the anvil member being attachable to the connection member of the tubular body. The assembly further includes a hub including a central sleeve defining a lumen therethrough for selectively receiving the anvil shaft therein, and an annular structure radially extending from the central sleeve, wherein when the center hub is positioned on the anvil shaft the support structure is concentrically located with respect to a longitudinal axis of the anvil shaft.

According to yet another aspect of the present disclosure, a method of disposing an annular structure between adjacent tissue sections is provided. The method includes the steps of: a) providing a surgical stapling device including an anvil assembly and a body portion, the anvil assembly including an anvil member supported on an anvil shaft and the body portion carrying a plurality of surgical staples and a knife; b) providing a hub for locating a support structure between the adjacent tissue sections, the hub including a central sleeve defining a lumen which is configured and adapted for selectively receiving the shaft of the anvil assembly therein, and an annular structure operatively connected to the central sleeve and extending radially outwardly therefrom; c) inserting the anvil assembly into a first tissue section; and d) positioning the hub onto the anvil shaft such that the annular structure is concentrically located with respect to a longitudinal axis of the anvil shaft and such that the annular structure is positioned adjacent to the first tissue section.

The method further includes the steps of: a) inserting the body portion in a second tissue section; b) approximating the anvil assembly and body portion with one another so that an end portion of the first tissue section, an end portion of the second tissue section and the annular structure are disposed between the anvil member and the body portion, wherein the annular structure is disposed between the first tissue section and the second tissue section; c) deploying the staples from the body portion; and d) cutting the first tissue section, the second tissue section, and the annular structure with the knife.

The hub may include an annular flange monolithically formed with and extending from the central sleeve. The flange may extend from a first end of the central sleeve.

The central sleeve may include a plurality of longitudinally extending slots formed around a periphery thereof. Each elongate slot may extend through one end of the central sleeve. The slots may be defined by a plurality of flexible fingers.

The annular structure may be fabricated from at least one of a bioabsorbable and a non-bioabsorbable material. It is envisioned that the annular structure may include a material selected from the group consisting of an adhesive, a sealant, a hemostat, and a medicament.

The annular structure may include an outer annular disc defining a central opening having a dimension larger than an outer diameter of the central sleeve, and a web interconnecting the disc to the central sleeve.

BRIEF DESCRIPTION OF DRAWINGS

The accompanying drawings, which are incorporated in and constitute a part of this specification, illustrate embodiments of the disclosure and, together with a general description of the disclosure given above and the detailed description of the embodiments given below, serve to explain the principles of the disclosure, wherein:

FIG. 1 is a perspective view of an exemplary annular surgical stapling device;

FIG. 2 is a perspective view of a hub according to an embodiment of the present disclosure for use with the surgical stapling device of FIG. 1;

FIG. 3 is a perspective view of the hub of FIG. 2 including an annular structure operatively associated therewith;

FIG. 4 is a perspective view of the intestinal area of a patient, illustrating a method of using the annular surgical stapling device of FIG. 1; and

FIG. 5 is an enlarged side elevational view of the anvil assembly of FIG. 4, illustrating the hub of FIG. 3 positioned on the anvil rod thereof.

DETAILED DESCRIPTION OF EMBODIMENTS

Embodiments of the presently disclosed center hub will now be described in detail with reference to the drawing figures wherein like reference numerals identify similar or identical elements. As used herein and as is traditional, the term "distal" refers to that portion which is furthest from the user while the term "proximal" refers to that portion which is closest to the user.

Referring initially to FIG. 1, an annular surgical stapling device, for use with the annular adhesive structures disclosed herein, is generally designated as 10. Surgical stapling device 10 includes a handle assembly 12 having at least one pivotable actuating handle member 14, and an advancing member 16. Extending from handle member 12, there is provided a tubular body portion 20 which may be constructed so as to have a curved shape along its length. Body portion 20 terminates in a staple cartridge assembly 22 which includes a pair of annular arrays of staple receiving slots 36 having a staple (not shown) disposed in each one of staple receiving slots 36. The body portion 20 includes a connection member 40 extending distally therefrom. An anvil assembly 30 has an anvil member 26 and an anvil rod 28 operatively associated therewith. The anvil rod 28 removably connects anvil assembly 30 to connection member 40 so that the anvil assembly 30 is positioned distally of staple cartridge assembly 22 of stapling device 10.

Staple cartridge assembly 22 may be fixedly connected to the distal end of tubular body portion 20 or may be configured to concentrically fit within the distal end of tubular body portion 20. Typically, staple cartridge assembly 22 includes a staple pusher (not shown) including a proximal portion having a generally frusto-conical shape and a distal portion defining two concentric rings of peripherally spaced fingers (not shown), each one of which is received within a respective staple receiving slot 36.

Typically, a knife (not shown), substantially in the form of an open cup with the rim thereof defining a knife edge, is disposed within staple cartridge assembly 22 and mounted to a distal surface of the staple pusher (not shown). The knife edge is disposed radially inward of the pair of annular arrays of staples. Accordingly, in use, as the staple pusher is advanced, the knife is also advanced axially outward.

Reference may be made to U.S. Pat. No. 5,915,616 to Viola et al., the entire content of which is incorporated herein by reference, for a detailed discussion of annular stapling device 10.

Turning now to FIGS. 2 and 3, a hub 100, in accordance with an embodiment of the present disclosure, is shown and is described below. Hub 100 is intended to be used with stapling device 10, described above. Hub 100 is intended to locate and secure an annular structure 200 relative to anvil rod 28 of anvil assembly 30.

As seen in FIGS. 2 and 3, hub 100 includes a central sleeve 102 defining a central lumen 104 and a longitudinal axis "X". Hub 100 includes an annular flange 106 extending radially outwardly from a first end 102a of central sleeve 102. As seen in FIGS. 2 and 3, flange 106 may be orthogonally oriented with respect to the longitudinal "X" axis. Flange 106 is desirably monolithically formed with central sleeve 102. Central sleeve 102 is configured and dimensioned to selectively receive anvil rod 28 of anvil assembly 30 therethrough.

Central sleeve 102 forms a connection portion for connecting to the surgical stapling device 10. Central sleeve 102 includes a plurality of longitudinally oriented elongate slots 108 formed therethrough. In an embodiment, each elongate slot 108 extends though a second end 102b of central sleeve 102. Elongate slots 108 define a plurality of fingers 110 therebetween. As seen in FIGS. 2 and 3, each elongate slot 108 may extend through first end 102a of central sleeve 102. In this manner, each finger 110 is flexible and/or deflectable either radially inward or radially outward.

Hub 100 may be fabricated from a material suitably rigid so as to accurately locate hub 100 relative to anvil shaft 28 of anvil assembly 30 and suitably flexible so as to enable fingers 110 to deflect as needed, in the manner described above. Additionally, hub 100 may be fabricated from a material suitable for ethylene oxide (EtO) and/or gamma sterilization. Hub 100 may be fabricated from, and is not limited to, acrylonitrile butadiene styrene (ABS), glass filled polypropylene or some combination thereof. It is envisioned that hub 100 may be plastic injection molded or manufactured from any other suitable method known by one having skill in the art, such as, for example, machining, stamping and/or the like.

With particular reference to FIG. 3, hub 100 is shown having an annular structure 200 operatively associated therewith. Annular structure 200 includes an outer circular disc 202 defining a central opening 202a and a web 204 extending radially inward of central opening 202a of disc 202 and terminating in opening 204a. In an embodiment, central opening 202a has a dimension which is larger than an outer diameter of flange 106 of hub 100. As seen in FIG. 3, web 204 may extend from disc 202 to flange 106 of hub 100.

In an embodiment, disc 202 of annular structure 200 is sized such that an outer edge 202b thereof extends radially outward beyond staple retaining pockets 36 of staple cartridge assembly 22. Additionally, disc 202 of annular structure 200 is sized such that opening 204a is sized such that disc 202 extends radially inward beyond staple retaining pockets 36 of staple cartridge assembly 22.

It is contemplated that disc 202 of annular structure 200 may be fabricated from or include a surgical grade, biocompatible, non-absorbable (i.e., permanent) material; desirably a mesh impregnated with an adhesive, sealant and/or wound treatment material. For example, disc 202 may be fabricated from "TEFLON", which is a registered trademark owned by DuPont de Nemours & Co. It is further contemplated that disc 202 may be fabricated from a biocompatible polymeric foam, felt, polytetrafluoroethylene (ePTFE), gelatin, fabric or the like, or any other biocompatible material.

Non-absorbable materials used for disc 202 include, and are not limited to, those that are fabricated from such polymers as polyethylene, polypropylene, nylon, polyethylene terephthalate, polytetrafluoroethylene, polyvinylidene fluoride, and the like. Further non-absorbable materials include and are not limited to stainless steel, titanium and the like.

In one embodiment, disc 202 of annular structure 200 may be fabricated from a bio-absorbable material which is desirably impregnated with an adhesive, sealant, and/or other wound treatment material (e.g., a medicament). Accordingly, a sealant component of annular structure 200 can be used to retard any bleeding which may occur from the tissue, an adhesive component of annular structure 200 can be used to secure the approximated tissue together, and the bio-absorbability of annular structure 200 allows for annular structure 200 to be absorbed into the body after a predetermined amount of time. For example, annular structure 200 may remain in place in the body for approximately 2-3 weeks in order for the anastomosis to sufficiently heal prior to annular structure 200 being absorbed into the body. In other embodiments, annular structure 200 has at least one portion that is absorbable and at least one portion that is not absorbable.

Bio-absorbable materials used for disc 202 of annular structure 200 include, and are not limited to, those fabricated from homopolymers, copolymers or blends obtained from one or more monomers selected from the group consisting of glycolide, glycolic acid, lactide, lactic acid, p-dioxanone, a-caprolactone and trimethylene carbonate. Other bio-absorbable materials include and are not limited to, for example, Polyglycolic Acid (PGA) and Polylactic Acid (PLA). In one embodiment, disc 202 may be fabricated from bio-absorbable felt, ePTFE, gelatin or any other bio-absorbable materials.

It is contemplated that the adhesive is a biocompatible adhesive including, but not limited to, adhesives which cure upon tissue contact, which cure upon exposure to ultraviolet (UV) light, which are two-part systems which are kept isolated from one another and cure upon coming into contact with one another, which are pressure sensitive, which are any combinations thereof, or any other known suitable adhesive. In one embodiment, it is contemplated that an adhesive having a cure time of from about 10 to 15 seconds may be used. In another embodiment, it is contemplated that an adhesive having a cure time of about 30 seconds may be used.

It is envisioned that disc 202 of annular structure 200 may be impregnated with a pre-cured adhesive or sealant. The pre-cured sealant or adhesive will react with the moisture and/or heat of the body tissue to thereby activate the sealing and/or adhesive properties of the sealant or adhesive. It is envisioned that the pre-cured sealant or adhesive may be a hydro-gel or the like.

It is envisioned that the wound treatment material "W" includes and is not limited to one or a combination of adhesives, hemostats, sealants, coagulants, astringents, and medicaments. Other surgically biocompatible wound treatment materials "W" which may be employed in or applied by surgical instruments, including surgical staplers, include adhesives whose function is to attach or hold organs, tissues or structures; sealants to prevent fluid leakage; hemostats to halt or prevent bleeding; coagulants, astringents (e.g., sulfates of aluminum) and medicaments. Examples of adhesives which can be employed include protein derived, aldehyde-based adhesive materials, for example, the commercially available albumin/glutaraldehyde materials sold under the trade designation BioGlue.TM. by Cryolife, Inc., and cyanoacrylate-based materials sold under the trade designations Indermil.TM. and Derma Bond.TM. by Tyco Healthcare Group, LP and Ethicon Endosurgery, Inc., respectively. Examples of sealants, which can be employed, include fibrin sealants and collagen-based and synthetic polymer-based tissue sealants. Examples of commercially available sealants are synthetic polyethylene glycol-based, hydrogel materials sold under the trade designation CoSeal.TM. by Cohesion Technologies and Baxter International, Inc. Examples of hemostat materials, which can be employed, include fibrin-based, collagen-based, oxidized regenerated cellulose-based and gelatin-based topical hemostats. Examples of commercially available hemostat materials are fibrinogen-thrombin combination materials sold under the trade designations CoStasis.TM. by Tyco Healthcare Group, LP, and Tisseel.TM. sold by Baxter International, Inc.

The wound treatment material may include a cross-linking material and/or reactive agent that reacts with the support structure, tissue or both. The resulting material acts as a seal or tissue-joining material that is non-absorbable. For example, the wound treatment material may be based on biocompatible cross-linked polymers formed from water soluble precursors having electrophilic and nucleophilic groups capable of reacting and cross-linking in situ, including those disclosed in U.S. Pat. No. 6,566,406, the entire contents of which are incorporated herein by reference.

The wound treatment material may be disposed on annular structure 200 or impregnated into annular structure 200. Medicaments may include one or more medically and/or surgically useful substances such as drugs, enzymes, growth factors, peptides, proteins, dyes, diagnostic agents or hemostasis agents, monoclonal antibodies, or any other pharmaceutical used in the prevention of stenosis.

Wound treatment material "W" may include visco-elastic film forming materials, cross-linking reactive agents, and energy curable adhesives. It is envisioned that wound treatment material "W", and in particular, adhesive may be cured with the application of water and/or glycerin (e.g., 1,2,3-pranatetriol, also known as glycerol and glycerine) thereto. In this manner, the water and/or glycerin cure the adhesive and hydrate the wound.

It is further contemplated that wound treatment material "W" may include, for example, compositions and/or compounds which accelerate or beneficially modify the healing process when particles of the composition and/or compound are applied to or exposed to a surgical repair site. For example, the wound treatment material "W" may be a therapeutic agent which will be deposited at the repair site. The therapeutic agent can be chosen for its antimicrobial properties, capability for promoting repair or reconstruction and/or new tissue growth. Antimicrobial agents such as broad spectrum antibiotic (gentamycin sulfate, erythromycin or derivatized glycopeptides) which are slowly released into the tissue can be applied in this manner to aid in combating clinical and sub-clinical infections in a tissue repair site. To promote repair and/or tissue growth, wound treatment material "W" may include one or several growth promoting factors, e.g., fibroblast growth factor, bone growth factor, epidermal growth factor, platelet derived growth factor, macrophage derived growth factor, alveolar derived growth factor, monocyte derived growth factor, magainin, and so forth. Some therapeutic indications are: glycerol with tissue or kidney plasminogen activator to cause thrombosis, superoxide dimutase to scavenge tissue damaging free radicals, tumor necrosis factor for cancer therapy or colony stimulating factor and interferon, interleukin-2 or other lymphokine to enhance the immune system.

In one embodiment, it is contemplated that disc 202 of annular structure 200 may be impregnated with a first component of a two-part adhesive and that the device deploys the second component of the two-part adhesive. For example, in a surgical stapler 10, the staples, which are retained in staple receiving slots 36 of staple cartridge assembly 22, may be coated with a second component (e.g., a reactant) of the two-part adhesive. In this manner, the first component of the adhesive is activated when the staples penetrate and capture disc 202 of annular structure 200 during the firing sequence of surgical stapling device 10, and the two components of the adhesive contact one another.

It is further envisioned that annular structure 200 may include a single layered disc 202 including a homogeneous array of bio-absorbable or non-absorbable materials or a heterogeneous array of bio-absorbable and/or non-absorbable materials. In certain embodiments, disc 202 may be impregnated with a pressure sensitive adhesive which is activated when adjacent layers of tissue are approximated, with disc 202 disposed therebetween.

In an alternate embodiment, it is contemplated that annular structure 200 may include a layered body portion having at least two layers. In this embodiment, each layer may include a homogeneous or heterogeneous array of bio-absorbable and/or non-absorbable materials. It is envisioned that each layer may be separated from one another prior to the surgical procedure. In certain embodiments, the annular structure 200 includes the structures disclosed in U.S. patent application Ser. Nos. 11/241,267 and 11/248,846, the disclosures of which are hereby incorporated by reference herein in their entirety.

With continued reference to FIG. 3, web 204 may be fabricated from any suitable mesh or the like. As seen in FIG. 3, web 204 of annular structure 200 is secured to flange 106 of hub 100 in such a manner that disc 202 is concentric with central sleeve 102 and with the longitudinal "X" axis.

Turning now to FIGS. 4 and 5, there is illustrated the use of surgical stapling device 10 and hub 100 in an anastomosis procedure to effect joining of intestinal sections 66 and 68. The anastomosis procedure is typically performed using minimally invasive surgical techniques including laparoscopic means and instrumentation. At the point in the procedure shown in FIG. 4, a diseased intestinal section has been previously removed, anvil assembly 30 has been introduced to the operative site either through a surgical incision or trans-anally and positioned within intestinal section 68, and tubular body portion 20 of surgical stapling device 10 has been inserted trans-anally into intestinal section 66. Intestinal sections 66 and 68 are also shown temporarily secured about their respective components (e.g., shaft 28 of anvil assembly 30, and the distal end of tubular body portion 20) by conventional means such as a purse string suture "P".

As seen in FIG. 5, hub 100 is attached onto shaft 28 of anvil assembly 30, prior to the coupling of anvil assembly 30 to the distal end of tubular body portion 20, and either before or after the anvil assembly is secured to intestinal section 68. In particular, shaft 28 of anvil assembly 30 is inserted through first end 102a of central sleeve 102 into lumen 104 of central sleeve 102. In this position, annular structure 200 is located adjacent intestinal section 68. Following positioning of hub 100 onto shaft 28 of anvil assembly 30, the surgeon maneuvers anvil assembly 30 until the proximal end of shaft 28 is connected to connection member 40 of surgical stapling device 10, wherein the mounting structure (not shown) engages shaft 28 to effect the connection. As shown in FIG. 5, the shaft 28 of the anvil assembly 30 has a feature, such as a protrusion or recess or flange 101, for engagement by hub 100. The fingers 110 are desirably flexible to assist the hub 100 and annular structure 200 onto shaft 28. In other embodiments, a shaft associated with the body portion 20 has a feature for engagement by the hub 100.

Thereafter, while ensuring disc 202 of annular structure 200 is extending radially outward, anvil assembly 30 and tubular body portion 20 are approximated to approximate intestinal sections 66, 68 and capture disc 202 of annular structure 200 therebetween. With disc 202 of annular structure 200 captured between intestinal sections 66, 68, surgical stapling device 10 may be fired thereby stapling intestinal sections 66, 68 to one another, securing disc 202 of annular structure 200 between intestinal section 66, 68, and cutting the portion of tissue and annular structure 200 disposed radially inward of the knife, to complete the anastomosis.

Hub 100 is removed from the surgical site upon withdrawal of surgical stapling device 10 from the surgical site. The hub 100 locates the annular structure 200 on the surgical stapling device 10 so that it is positioned at the desired location with respect to the portions of tissue being joined. The procedure is simplified in that the annular structure 200 may not need to be positioned on shaft 28 inside the patients body.

It will be understood that various modifications may be made to the embodiments of the presently disclosed surgical stapling apparatus and the various dispensing systems and methods described above. For example, the hub and annular structure may be used on a surgical device for positioning the annular structure, that does not deploy staples. Such surgical devices may incorporate a wound treatment material dispensing apparatus. Therefore, the above description should not be construed as limiting, but merely as exemplifications of preferred embodiments. Those skilled in the art will envision other modifications within the scope and spirit of the present disclosure.

* * * * *

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.